These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15051567)

  • 1. Routine follow-up visits after first-trimester induced abortion.
    Grossman D; Ellertson C; Grimes DA; Walker D
    Obstet Gynecol; 2004 Apr; 103(4):738-45. PubMed ID: 15051567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of mifepristone and misoprostol administered at the same time for abortion up to 49 days gestation.
    Murthy AS; Creinin MD; Harwood B; Schreiber C
    Contraception; 2005 May; 71(5):333-6. PubMed ID: 15854632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion.
    Honkanen H; Piaggio G; Hertzen H; Bártfai G; Erdenetungalag R; Gemzell-Danielsson K; Gopalan S; Horga M; Jerve F; Mittal S; Thi Nhu Ngoc N; Peregoudov A; Prasad RN; Pretnar-Darovec A; Shah RS; Song S; Tang OS; Wu SC;
    BJOG; 2004 Jul; 111(7):715-25. PubMed ID: 15198763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the quality of three models of postabortion care in public hospitals in Mexico City.
    Billings DL; Fuentes Velásquez J; Pérez-Cuevas R
    Int Fam Plan Perspect; 2003 Sep; 29(3):112-20. PubMed ID: 14519587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where do rural women obtain postabortion care? The case of Uttar Pradesh, India.
    Johnston HB; Ved R; Lyall N; Agarwal K
    Int Fam Plan Perspect; 2003 Dec; 29(4):182-7. PubMed ID: 14665427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of preabortion counseling on postabortion contraceptive use.
    Bender SS; Geirsson RT
    Contraception; 2004 Jun; 69(6):481-7. PubMed ID: 15157793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and acceptability with the use of a contraceptive vaginal ring after surgical or medical abortion.
    Fine PM; Tryggestad J; Meyers NJ; Sangi-Haghpeykar H
    Contraception; 2007 May; 75(5):367-71. PubMed ID: 17434018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?
    Leeman L; Asaria S; Espey E; Ogburn J; Gopman S; Barnett S
    Contraception; 2007 Aug; 76(2):96-100. PubMed ID: 17656177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-physician clinicians can safely provide first trimester medical abortion.
    Yarnall J; Swica Y; Winikoff B
    Reprod Health Matters; 2009 May; 17(33):61-9. PubMed ID: 19523583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors associated with presenting for abortion in the second trimester.
    Drey EA; Foster DG; Jackson RA; Lee SJ; Cardenas LH; Darney PD
    Obstet Gynecol; 2006 Jan; 107(1):128-35. PubMed ID: 16394050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical versus surgical abortion efficacy, complications and leave of absence compared in a partly randomized study.
    Rørbye C; Nørgaard M; Nilas L
    Contraception; 2004 Nov; 70(5):393-9. PubMed ID: 15504379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for complications of induced abortions in Nigeria.
    Mitsunaga TM; Larsen UM; Okonofua FE
    J Womens Health (Larchmt); 2005; 14(6):515-28. PubMed ID: 16115006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scaling up post-abortion care in Guatemala: initial successes at national level.
    Kestler E; Valencia L; Del Valle V; Silva A
    Reprod Health Matters; 2006 May; 14(27):138-47. PubMed ID: 16713888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The after-care of abortion patients.
    Ashton JR
    J R Coll Gen Pract; 1981 Apr; 31(225):217-22. PubMed ID: 6268784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion.
    Rossi B; Creinin MD; Meyn LA
    Contraception; 2004 Oct; 70(4):313-7. PubMed ID: 15451336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.
    Akin A; Dabash R; Dilbaz B; Aktün H; Dursun P; Kiran S; Aksan G; Doğan B; Winikoff B
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):169-75. PubMed ID: 19565414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion.
    Stanek AM; Bednarek PH; Nichols MD; Jensen JT; Edelman AB
    Contraception; 2009 Mar; 79(3):216-20. PubMed ID: 19185676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.